Dextrue 20 Infusion contains Dextrose 20% w/v, a hypertonic intravenous solution used for hydration, energy supplementation, and as a carrier for medications in clinical settings. It delivers concentrated glucose to patients requiring additional caloric intake or correction of hypoglycemia.
This infusion is widely employed in hospitals, emergency care, and specialized therapy units to provide rapid energy support, maintain blood glucose levels, and supply essential calories intravenously. Its high osmolarity makes it suitable for select patient populations under medical supervision.
For distributors, hospital suppliers, and institutional wholesalers, Dextrue 20 Infusion is a high-demand IV hypertonic solution, frequently required in ICU, surgery units, oncology supportive care, and critical care settings. Regular clinical use ensures steady procurement and predictable market demand.
Adding Dextrue 20 Infusion to your portfolio strengthens your hospital care and energy supplementation segment, creating supply opportunities across institutional orders, hospital procurement, government tenders, export consignments, and third-party manufacturing. Its vital role in patient hydration and energy management makes it a profitable and strategically important product for pharmaceutical distributors.